Details of the Drug Reposition

General Information of This Drug (ID: DMDGCHR)

Drug Name
NN-1218   DMDGCHR

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diabetic complication DIS4S2FC 5A2Y Phase 1 [1]
------------------------------------------------------------------------------------
2 Application submitted Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-1 diabetes DIS7HLUB 5A10 Application submitted [2]
Type-2 diabetes DIS3X247 5A11 Application submitted [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01121289) A Trial Investigating NN1218 in Subjects With Type 1 Diabetes. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)